Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Insulin Resistance 2Inflammation 2Hyperandrogenism 2Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Anovulation 1

Interventions

Clomiphene 10Metformin 9Letrozole 3Medroxyprogesterone Acetate 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Ultrasonography 1Tamoxifen 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Inulin 1Inositol 1Hematologic Tests 1Glycoprotein Hormones, alpha Subunit 1Folic Acid 1Flutamide 1Chorionic Gonadotropin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anovulation × salicylsalicylic acid × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡